CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 46 filers reported holding CASI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $19,000 | -48.6% | 24,041 | -47.4% | 0.00% | – |
| Q4 2021 | $37,000 | -19.6% | 45,663 | +16.5% | 0.00% | – |
| Q3 2021 | $46,000 | -32.4% | 39,185 | -9.5% | 0.00% | – |
| Q2 2021 | $68,000 | +466.7% | 43,285 | +781.2% | 0.00% | – |
| Q1 2021 | $12,000 | -92.8% | 4,912 | -91.3% | 0.00% | – |
| Q4 2020 | $166,000 | +730.0% | 56,188 | +331.6% | 0.00% | – |
| Q3 2020 | $20,000 | -58.3% | 13,019 | -31.5% | 0.00% | – |
| Q2 2020 | $48,000 | +269.2% | 18,998 | +203.5% | 0.00% | – |
| Q1 2020 | $13,000 | -94.0% | 6,260 | -91.1% | 0.00% | – |
| Q4 2019 | $217,000 | +301.9% | 70,324 | +331.2% | 0.00% | – |
| Q3 2019 | $54,000 | +390.9% | 16,308 | +357.2% | 0.00% | – |
| Q2 2019 | $11,000 | -68.6% | 3,567 | -70.4% | 0.00% | – |
| Q1 2019 | $35,000 | -89.7% | 12,035 | -85.7% | 0.00% | – |
| Q4 2018 | $339,000 | -22.1% | 84,427 | -9.4% | 0.00% | – |
| Q3 2018 | $435,000 | -64.1% | 93,166 | -36.7% | 0.00% | – |
| Q2 2018 | $1,213,000 | +204.8% | 147,257 | +54.2% | 0.00% | – |
| Q1 2018 | $398,000 | +182.3% | 95,512 | +118.2% | 0.00% | – |
| Q4 2017 | $141,000 | +6950.0% | 43,767 | +3682.8% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 1,157 | +2.1% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 1,133 | -16.6% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 1,358 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 1,358 | +30.5% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 1,041 | +2.6% | 0.00% | – |
| Q2 2016 | $1,000 | – | 1,015 | +191.7% | 0.00% | – |
| Q1 2016 | $0 | – | 348 | +5.8% | 0.00% | – |
| Q4 2015 | $0 | – | 329 | +20.5% | 0.00% | – |
| Q3 2015 | $0 | – | 273 | -17.0% | 0.00% | – |
| Q2 2015 | $0 | – | 329 | +0.6% | 0.00% | – |
| Q1 2015 | $0 | – | 327 | -0.3% | 0.00% | – |
| Q4 2014 | $0 | – | 328 | +1.5% | 0.00% | – |
| Q3 2014 | $0 | – | 323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |